26 /100
MEDIUM RISK
Score updated Apr 13, 2026

MLYS

Mineralys Therapeutics, Inc. — Stock Dilution Tracker

Track MLYS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track MLYS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MLYS.
🔔 Track MLYS — Get forecast alerts →
💹 Market Data
Market Cap$2.19B
Shares Outstanding82.45M
Float60.24M
Cash$656.64M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 26.2% shares (2025Q4 vs prior)
227 institutional holders · 101.67M shares
#1 Catalys Pacific, LLC 7.90M shares
#2 RA CAPITAL MANAGEMENT, L.P. 7.32M shares
#3 SAMSARA BIOCAPITAL, LLC 5.87M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest8.37M
Days to Cover5.7
% of Float13.9%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Feb 07, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 31, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track MLYS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MLYS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required